Menu
Brokers
MT4 Forex Brokers
MT5 Forex brokers
PayPal Brokers
Skrill Brokers
Oil Trading Brokers
Gold Trading Brokers
Web Browser Platform
Brokers with CFD Trading
ECN Brokers
Bitcoin FX Brokers
PAMM Forex Brokers
With Cent Accounts
With High Leverage
Cryptocurrency Brokers
Forums
All threads
New threads
New posts
Trending
Search forums
What's new
New threads
New posts
Latest activity
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Reply to thread
Forums
Advertisements
Advertisements
The Most Promising Stocks for May according to Walletinvestor.com
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
[QUOTE="Dora_WalletInvestor, post: 195259, member: 68562"] [B]2. AbbVie Inc. [[URL='https://walletinvestor.com/stock-forecast/abbv-stock-prediction']ABBV[/URL]] [/B] [I]Sector: Healthcare Industry: Drug Manufacturers – General[/I] [u]Current price: $111.69 | 1 year: +15.81% | 5 years: +83.55%[/u] AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, hepatitis C, women’s health, oncology, and neuroscience. AbbVie also offers treatments for diseases including multiple sclerosis, parkinson’s, and alzheimer’s disease. Abbvie has a market cap of $196.97 with an enterprise value of $275.33 billion. Their price to sales ratio is 4.30 and their price to book ratio is 15.07. It is trading at $111.69 with a 52-week high of $113.41 and a 52-week low of $79.11. Their profit margin is 10.08% and their operating margin is 34.27%. About management effectiveness, their return on assets is 8.19% and their return on equity is 187.70%. The stock has an average 10-day volume of $5.16 million with outstanding shares of $1.76 billion. They had revenue of $45.8 billion which equals a revenue per share of $27.48. They are sitting on total cash of $8.49 billion and they have an operating cash flow of $17.59. The statistics are looking very well for the company, which means Abbvie could be a good long-term option for investors. [/QUOTE]
Insert quotes…
Verification
Post reply
Top
Bottom
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…